ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy

Liver Transplantation

Volumn 12, Issue 9, 2006, Pages 1412-1417

  Troisi, Robert ^a   Noens, Lucien ^a   Montalti, Roberto ^a   Ricciardi, Salvatore ^a   Philippé, Jan ^a   Praet, Marleen ^a   Conoscitore, Pasquale ^b   Centra, Michele ^c   de Hemptinne, Bernard ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Department of Gastroenterology ^*  (Italy)

^c Blood Transfusion Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; FLUCONAZOLE; GANCICLOVIR; HEMAGGLUTININ; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TEICOPLANIN; TEMOCILLIN;

ACUTE GRAFT REJECTION; ADULT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAINTENANCE DRUG DOSE; MALE; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; SPLENECTOMY; STATISTICAL SIGNIFICANCE;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP INCOMPATIBILITY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; SPLENECTOMY;

EID: 33748761641     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20727     Document Type: Article

References (28)

1. Gordon RD, Fung JJ, Markus B, Fox I, Iwatsuki S, Esquivel CO, et al. The antibody crossmatch in liver transplantation. Surgery 1986;100:705-715.
2. Farges O, Nocci Kalil A, Samuel D, Saliba F, Arunalden JL, Debat P, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995;59:1124-1133.
3. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990;336:519-523.
4. Paul LC, Baldwin WM III. Humoral rejection mechanisms and ABO incompatibility in renal transplantation. Transpl Proc 1987; 19:4463-4467.
5. Cooper DCK. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant 1990;9:376-381.
6. Hanto DW, Snover DC, Sibley RK, Nooren HJ, Gajl-Pezalska KJ, Najarian JS, et al. Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient. Clin Transplant 1987; 1:304-310.
7. Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz ME, Emre S, et al. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 1995;59:986-990.
8. Kozaki M, Kasahara M, Oike F, Ogawa K, Fujimoto Y, Ogura Y, et al. Apheresis therapy for living-donor liver transplantation. Ther Apher 2002;6:478-483.
9. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003;9:22-30.
10. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003;76:730-743.
11. Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg 2003;237:429-436.
12. Steagall M. ABO-incompatible liver transplant: is it justifiable? Liver Transpl 2003;9:31.
13. Egawa H, Oike F, Buhler L, Shapiro AMJ, Minamiguchi S, Haga H, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004;77:403-411.
14. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med Rev 2001;11:325-342.
15. Matic G, Hofmann D, Winkler R, Tiess M, Michelsen A, Schneidewind JM, et al. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption. Artif Organs 2000;24:103-107.
16. Troisi R, Hesse UJ, Decruyenaere J, Morelli MC, Palazzo U, Pattyn P, et al. Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant 1999;13:380-388.
17. Hashimoto T, Kondo S, Suzuki T, Nakamura T, Shimizu Y, Nakamura Y, et al. Strategy for ABO-incompatible living-related liver transplantation. Transpl Proc 2000;32:2104-2106.
18. Ishida H, Koyama I, Sawada T, Utsumi K, Murakami T, Sannomiya A, et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 2000;70:681-685.
19. Fang WC, Saltzman J, Rososhansky S, Szabo G, Heard SO, Banner B, et al. Acceptance of an ABO-incompatible mismatched (AB+ to 0+) liver allograft with the use of daclizumab and mycophenolate mofetil. Liver Transpl 2000;6:497-500.
20. Usuda M, Fujimori K, Koyamada N, Fukumori T, Sekiguchi S, Kawagishi N, et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living related liver transplantation. Transplantation 2005; 79:12-16.
21. Boillot O, Mayer DA, Boudjema K, Salizzoni M, Gridelli B, Filipponi F, et al. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Liver Transpl 2005;11: 61-67.
22. Morrissey PE, Gordon F, Shaffer D, Madras PN, Silva P, Sahyoun AI, et al. Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg 1998;4:363-369.
23. Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004;10:16-27.
24. Nydegger UE, Rieben R, Carrel T, Mohacsi P. Solid organ transplantation across the ABO histo-blood group barrier: a case report. Transplant Proc 2004;36:1554-1557.
25. Egawa H, Inomata Y, Uemoto S, Asonuma K, Kiuchi T, Fujita S, et al. Biliary anastomotic complications in 400 living related liver transplantations. World J Surg 2001; 25:1300-1307.
26. Gondolesi GE, Varotti G, Florman SS, Muñoz L, Fishbein TM, Emre SH, et al. Biliary complications in 96 consecutive right lobe living donor liver transplant recipients. Transplantation 2004;77:1842-1848.
27. Hayashi S, Noguchi K, Yagihashi A, Starzl TE, Iwaki Y. Expression of blood group antigen (A,B,H, Le(a), Le(b)) on liver allografts. Transplant Proc 1992;24:2567-2568.
28. Trotter JF. Living donor liver transplantation: is the hype over? J Hepatol 2005;42:20-25.